Filing Details

Accession Number:
0001123292-14-001043
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-02 17:13:04
Reporting Period:
2014-11-28
Filing Date:
2014-12-02
Accepted Time:
2014-12-02 17:13:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1175505 Five Prime Therapeutics Inc FPRX Pharmaceutical Preparations (2834) 260038620
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1273885 M Franklin Berger C/O Five Prime Therapeutics, Inc.
Two Corporate Drive
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-28 851 $21.04 851 No 4 P Direct
Common Stock Acquisiton 2014-11-28 1,100 $21.04 1,951 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct